rs146770430
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_033087.4(ALG2):c.475A>G(p.Ile159Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000809 in 1,614,172 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_033087.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 14Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- ALG2-congenital disorder of glycosylationInheritance: Unknown, AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, PanelApp Australia, Orphanet, Ambry Genetics
- congenital myasthenic syndromes with glycosylation defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALG2 | NM_033087.4 | c.475A>G | p.Ile159Val | missense_variant | Exon 2 of 2 | ENST00000476832.2 | NP_149078.1 | |
| ALG2 | XM_047423996.1 | c.196A>G | p.Ile66Val | missense_variant | Exon 2 of 2 | XP_047279952.1 | ||
| ALG2 | NR_024532.2 | n.682A>G | non_coding_transcript_exon_variant | Exon 3 of 3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ALG2 | ENST00000476832.2 | c.475A>G | p.Ile159Val | missense_variant | Exon 2 of 2 | 1 | NM_033087.4 | ENSP00000417764.1 | ||
| ALG2 | ENST00000319033.7 | c.196A>G | p.Ile66Val | missense_variant | Exon 2 of 2 | 1 | ENSP00000326609.6 | |||
| ALG2 | ENST00000238477.5 | n.*217A>G | non_coding_transcript_exon_variant | Exon 3 of 3 | 2 | ENSP00000432675.2 | ||||
| ALG2 | ENST00000238477.5 | n.*217A>G | 3_prime_UTR_variant | Exon 3 of 3 | 2 | ENSP00000432675.2 |
Frequencies
GnomAD3 genomes AF: 0.000605 AC: 92AN: 152168Hom.: 1 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000720 AC: 181AN: 251480 AF XY: 0.000773 show subpopulations
GnomAD4 exome AF: 0.000830 AC: 1214AN: 1461886Hom.: 3 Cov.: 31 AF XY: 0.000851 AC XY: 619AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000604 AC: 92AN: 152286Hom.: 1 Cov.: 33 AF XY: 0.000618 AC XY: 46AN XY: 74470 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:4
- -
ALG2: BP4 -
- -
- -
ALG2-congenital disorder of glycosylation;C4015597:Congenital myasthenic syndrome 14 Uncertain:1Benign:1
- -
- -
ALG2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
See cases Benign:1
ACMG classification criteria: BP1, BP4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at